Novartis OTC Habitrol Taking Private Label Tack
This article was originally published in The Tan Sheet
Executive Summary
Novartis Consumer Health is planning a "major" private label initiative with its newly approved OTC nicotine patches involving Wal-Mart, CVS and Walgreens. The firm intends to later market the product under its original Habitrol name, but the initial focus is in the private label setting. OTC Habitrol was approved Nov. 12.
You may also be interested in...
Novartis Tavist ND Loratadine Tablets Carry Geneva’s Marketing Exclusivity
Geneva Pharmaceuticals initially will market the first generic competition to Schering-Plough's OTC Claritin behind pharmacy counters
Novartis Tavist ND Loratadine Tablets Carry Geneva’s Marketing Exclusivity
Geneva Pharmaceuticals initially will market the first generic competition to Schering-Plough's OTC Claritin behind pharmacy counters
Novartis Tavist ND Loratadine Tablets Carry Geneva’s Marketing Exclusivity
Geneva Pharmaceuticals initially will market the first generic competition to Schering-Plough's OTC Claritin behind pharmacy counters